Nakamoto Inc., a Bitcoin treasury company trading under the ticker NAKA, has drawn fresh attention after investors questioned why a crypto-focused public company has a Chief Medical Officer on staff. The role went viral online as critics used it as an example of what they see as excess inside the fast-growing Digital Asset Treasury sector.
The company’s explanation is simple: Nakamoto did not begin as a pure Bitcoin treasury firm. It emerged from a reverse merger involving KindlyMD, a Utah-based pain management provider that was already listed on Nasdaq before merging with David Bailey’s private Nakamoto Holdings in 2025.
Because KindlyMD was a healthcare business, its founder, Tim Pickett, remained with the company as Chief Medical Officer. According to Nakamoto CEO and Chairman David Bailey, the role exists because the company still maintains an operating healthcare subsidiary, which also helps satisfy Nasdaq listing requirements.
The explanation may be technically reasonable, but the controversy has reopened broader questions about Nakamoto’s corporate structure, shareholder dilution, debt load, operating losses and the sustainability of Bitcoin treasury companies.
Why Nakamoto Has a Chief Medical Officer
At first glance, a Chief Medical Officer at a Bitcoin treasury company appears unusual. Crypto treasury companies are usually judged by Bitcoin holdings, capital raises, share issuance, debt structure and premium or discount to net asset value. A medical executive does not naturally fit that profile.
But Nakamoto’s history explains the role. The company began as KindlyMD, a medical provider focused on pain management. KindlyMD later merged with Nakamoto Holdings, transforming the listed entity into a Bitcoin treasury vehicle while keeping the legacy healthcare business inside the corporate structure.
Bailey said the company has a Chief Medical Officer because it merged with a healthcare company and still needs to maintain an operating business. That operating business matters because it helps the company avoid being treated as a shell company.
The healthcare subsidiary also generates most of Nakamoto’s modest recurring revenue. In that sense, the medical role is not decorative. It is connected to the company’s legacy operating segment.
Reverse Mergers Create Unusual Corporate Structures
Nakamoto’s situation highlights how reverse mergers can create unusual public-company structures. In a reverse merger, a private company combines with an already listed public company to gain market access faster than through a traditional initial public offering.
This route can be attractive because it may reduce time, cost and regulatory complexity. But it can also leave behind legacy operations that do not perfectly match the new company’s public identity.
That is what happened with Nakamoto. The market now views it primarily as a Bitcoin treasury company. But legally and operationally, part of the old healthcare business remains.
This is why investors see a medical title inside a Bitcoin company. The position reflects the company’s origin, not necessarily its current investment narrative.
The Viral Role Became a Symbol of Broader Concerns
The Chief Medical Officer role became a punchline because it appeared at a time when Nakamoto was already under pressure. Critics were not only mocking the title. They were using it to question whether the company’s structure is too complex, too promotional or too expensive for public shareholders.
Analysts have pointed to Nakamoto’s steep share-price collapse, significant debt and large quarterly losses. According to the figures cited, the company reported a $238 million net loss in the first quarter of 2026, while operating revenue was only $2.3 million.
That gap is large enough to concern investors. A company can hold Bitcoin and still face serious questions if its operating expenses, compensation, acquisition accounting or financing structure create heavy losses.
The viral medical-role debate therefore became a shortcut for a deeper issue: whether Nakamoto’s corporate model creates enough shareholder value to justify its complexity.
Dilution Is the Main Investor Concern
The bigger issue for many shareholders is dilution. Nakamoto acquired BTC Inc. and UTXO Management from Bailey and Chief Investment Officer Tyler Evans. The transaction reportedly diluted public holders by 58% in one quarter.
Dilution is particularly sensitive in Bitcoin treasury companies because shareholders often buy the stock to gain exposure to Bitcoin per share. If the number of shares rises sharply, investors may worry that their claim on the company’s Bitcoin holdings is being reduced.
A Bitcoin treasury strategy only works well for shareholders if capital raises, acquisitions and share issuance increase Bitcoin per share or improve long-term value. If transactions expand the company but reduce shareholder ownership too aggressively, the market can punish the stock.
That appears to be one reason Nakamoto has faced skepticism.
Losses and Compensation Add Pressure
The reported first-quarter figures also intensified criticism. Nakamoto generated $2.3 million in operating revenue, while insiders received $7.3 million in compensation. The company also reported a large net loss.
For investors, that raises questions about cost discipline. In a treasury-style company, operating efficiency matters. Shareholders usually want the company to preserve capital, accumulate Bitcoin intelligently and avoid unnecessary expenses.
High compensation relative to operating revenue can become a red flag, especially if the stock price is falling and public holders are being diluted.
This does not automatically mean the company’s strategy will fail. But it does mean Nakamoto needs to prove that its acquisitions, operating structure and leadership costs can produce value over time.
Reverse Stock Split Restores Nasdaq Compliance
Nakamoto shareholders approved a 1-for-40 reverse stock split to restore compliance with Nasdaq’s $1 minimum bid requirement. The split took effect on May 22 and lifted the share price from around $0.16 to roughly $6.
A reverse split does not change the company’s underlying value. It simply reduces the number of shares outstanding and increases the price per share proportionally. In Nakamoto’s case, the split compressed roughly 696 million outstanding shares into about 17.4 million.
The practical purpose was to avoid falling below Nasdaq’s listing requirements. But reverse splits can also carry negative market signaling. Investors often associate them with companies under pressure, especially when the move follows a major share-price decline.
For Nakamoto, the reverse split gives the company more time, but it does not answer the deeper questions about losses, dilution and strategy.
Bitcoin Holdings Are Not the Only Metric
Nakamoto’s headline Bitcoin holdings are significant. The company reportedly holds 5,058 BTC. For many Bitcoin treasury investors, that figure is the main attraction.
However, the article suggests investors may focus less on headline Bitcoin holdings over the next two quarters and more on the operating line. That is an important distinction.
A company can hold thousands of Bitcoin and still trade poorly if investors believe its structure reduces value per share. Bitcoin holdings matter, but so do debt, dilution, corporate expenses, acquisition costs, liquidity and governance.
The market is increasingly looking beyond the simple question of “how much Bitcoin does the company own?” The more important question may be: “How much Bitcoin exposure does each shareholder effectively own after dilution, debt and expenses?”
The BTC Inc. Acquisition Needs to Prove Its Value
One of the next major tests will be whether revenue from the Bitcoin 2026 conference can justify the goodwill attached to the BTC Inc. acquisition. BTC Inc. is connected to major Bitcoin media and events, and the company likely expects that business to strengthen Nakamoto’s operating profile.
But investors will want evidence. Events revenue can be seasonal, and goodwill on acquisitions can become a problem if expected revenue or margins fail to materialize.
The Q2 10-Q, expected in August, will therefore be important. It should provide more clarity on whether the acquired assets are contributing meaningfully to revenue, cash flow and strategic value.
If BTC Inc. performs well, Nakamoto may be able to argue that it is more than a passive Bitcoin holder. If the results disappoint, criticism over dilution and insider-related transactions could intensify.
Insider Lock-Up Expiration Is Another Key Date
Another key event is the first insider lock-up tranche, scheduled to release on August 20. Lock-ups restrict insiders from selling shares for a certain period after major transactions. When they expire, the market watches closely to see whether insiders hold or sell.
If insiders continue holding, it may signal confidence. If significant selling occurs, it could increase pressure on the stock and worsen investor concerns.
For companies already facing dilution criticism, insider behavior is especially important. Shareholders want evidence that management’s interests are aligned with theirs.
What This Means for the Digital Asset Treasury Sector
Nakamoto’s situation is not only about one company. It reflects broader concerns across the Digital Asset Treasury sector.
Many companies have tried to follow the playbook of holding Bitcoin on the balance sheet and using public equity markets to finance accumulation. The strategy can work when share prices trade at a premium and capital can be raised efficiently.
But the model becomes risky when share prices collapse, dilution rises, debt grows or operating losses become difficult to explain.
Investors are becoming more selective. They are asking whether each company has transparent governance, disciplined capital allocation, sustainable operating costs and a credible plan to grow Bitcoin value per share.
Nakamoto has become a case study because its structure includes a healthcare subsidiary, a medical officer, major acquisitions, heavy dilution and a large Bitcoin treasury narrative.
Key Risks Investors Should Watch
The first risk is dilution. If Nakamoto continues issuing shares aggressively, investors may worry that their ownership is being reduced faster than value is being created.
The second risk is debt. A roughly $200 million debt load can become a burden if revenue does not grow or if Bitcoin volatility affects financing flexibility.
The third risk is operating performance. The legacy healthcare business provides recurring revenue, but it is modest. The acquired BTC-related businesses must prove they can generate meaningful results.
The fourth risk is governance. Related-party transactions, insider compensation and lock-up expirations will remain under close scrutiny.
The fifth risk is Bitcoin price volatility. Nakamoto’s market value will likely remain tied to Bitcoin sentiment, but company-specific factors can still cause the stock to underperform Bitcoin itself.
Nakamoto’s Chief Medical Officer role may look strange for a Bitcoin treasury company, but it has a clear explanation: the company emerged from a merger with KindlyMD, a healthcare provider, and still maintains that operating business.
The bigger issue is not the medical title itself. It is what the controversy reveals about investor concerns. Nakamoto faces questions about dilution, losses, compensation, debt, acquisition value and long-term shareholder alignment.
The company’s 5,058 BTC holdings remain central to its identity, but investors are increasingly focused on whether those holdings translate into real value per share. The upcoming Q2 filing and the August insider lock-up expiration could become major tests for market confidence.
For now, Nakamoto is a reminder that Bitcoin treasury companies are not judged by Bitcoin holdings alone. Structure, governance, dilution and operating discipline matter just as much.
